Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epaxal Paediatric Dose vs Standard Dose in Children
NCT01405677Phase 2Completed
- Sponsor
- Crucell
- Start
- Jun 2004
- Primary completion
- Apr 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Epaxal Junior in hepatitis A (HAV), sponsored by Crucell. Started Jun 2004; status: completed.
02
Drugs
Epaxal Junior
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT01405677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01405677.